Vynca Appoints Sandra Clarke to Board of Directors, Strengthening Commitment to Transformative Palliative Care
SOURCE Vynca, Inc.
SAN FRANCISCO, July 15, 2025 /PRNewswire/ -- Vynca, a healthcare services and software company that cares for individuals with serious illnesses and complex needs, today announced that Sandra Clarke was appointed to its Board of Directors in June 2025. Clarke, an accomplished executive with more than 25 years of experience in healthcare finance, operations, and transformation, brings a proven record of innovation and leadership from her roles at Blue Shield of California, Daiichi Sankyo, and Philips Healthcare.
"We are honored to welcome Sandra Clarke to our Board," said Vynca CEO Darren Schulte, M.D. "Clarke's exceptional track record at Blue Shield of California, where she drove operational transformation while improving patient and member outcomes, aligns perfectly with Vynca's mission to help people with serious illnesses spend more quality days at home™."
Clarke most recently served as Executive Vice President and Chief Operating Officer at Blue Shield of California, where she was responsible for more than $25 billion in annual revenue. During her tenure, she spearheaded innovative programs to reimagine pharmacy care and enhance the member experience. Clarke's leadership at Blue Shield was instrumental in driving the organization's turnaround to profitability and operational excellence. In addition, Clarke has held senior finance roles at Daiichi Sankyo and Philips Healthcare, where she managed global teams and complex business operations. She also served on the boards of several healthcare organizations, contributing her expertise in audit, risk, and governance.
Clarke's experience leading large-scale operational transformations is particularly relevant as Vynca leverages predictive analytics and artificial intelligence to shift care for seriously ill patients to proactive, orchestrated support in the home. The integration of predictive analytics into Vynca's clinical workflows represents an operational transformation at the intersection of care delivery and technology, requiring the same discipline, vision, and execution that Clarke has demonstrated throughout her career.
"I am honored to join Vynca's Board of Directors at such a pivotal time for the company and the field of palliative care," said Clarke. "I understand the profound impact that specialty palliative care can have on patients, families, and the healthcare system. Vynca's technology-enabled, patient-centered approach is setting a new standard for quality and accessibility in serious illness care, and I look forward to supporting the company's mission."
With this appointment, Vynca further strengthens its Board of Directors as it continues to expand its hybrid clinical model and proprietary technology platform to deliver high-quality, community-based palliative care and navigation nationwide.
About Vynca
Vynca is a health technology and services company transforming care for people living with serious illness and complex needs. Through specialty palliative care, care navigation, and intelligent care orchestration software, we help patients experience more quality days at home™. Our hybrid model combines in-person and virtual support with predictive technology to intervene early, reduce avoidable hospitalizations, and improve quality of life. Vynca orchestrates the right care at the right time, wherever patients are-because serious illness deserves serious support. Learn more at https://vyncacare.com.
Media Inquiries: Paige Swanepoel | paigeswanepoel@vyncacare.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/vynca-appoints-sandra-clarke-to-board-of-directors-strengthening-commitment-to-transformative-palliative-care-302504567.html

©PR Newswire. All Rights Reserved.
Information contained on this page is provided by an independent third-party content provider. XPRMedia and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact pressreleases@xpr.media